Display options
Share it on

Anaesth Crit Care Pain Med. 2020 Apr;39(2):179-183. doi: 10.1016/j.accpm.2020.03.007. Epub 2020 Mar 07.

The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation.

Anaesthesia, critical care & pain medicine

Jean-Jacques Rouby, Antoine Monsel, Marc Leone, Olivier Mimoz, Pierre-François Laterre, Jérôme Pugin

Affiliations

  1. Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique - Hôpitaux de Paris, Medicine Sorbonne University, Paris, France. Electronic address: [email protected].
  2. Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique - Hôpitaux de Paris, Medicine Sorbonne University, Paris, France.
  3. Department of Anaesthesiology and Critical Care, North Hospital, University Aix-Marseille, Marseille, France.
  4. Department of Anaesthesiology and Intensive Care, University Hospital of Poitiers, University of Poitiers, Poitiers, France.
  5. Saint Luc Clinical Coordinating Centre, Department of Critical Care Medicine, St Luc University Hospital, Catholic University of Louvain, Brussels, Belgium.
  6. Intensive Care Division, University Hospitals of Geneva, Geneva, Switzerland.

PMID: 32156643 DOI: 10.1016/j.accpm.2020.03.007

[No abstract available.]

Keywords: Amikacin; Epithelial lining fluid; Multidrug-resistant Gam-negative bacteria; Nebulised antibiotics; Tobramycin; Ventilator-associated pneumonia

Publication Types